WO2010050516A1 - Method for producing l-amino acid - Google Patents
Method for producing l-amino acid Download PDFInfo
- Publication number
- WO2010050516A1 WO2010050516A1 PCT/JP2009/068515 JP2009068515W WO2010050516A1 WO 2010050516 A1 WO2010050516 A1 WO 2010050516A1 JP 2009068515 W JP2009068515 W JP 2009068515W WO 2010050516 A1 WO2010050516 A1 WO 2010050516A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- amino acid
- carbon atoms
- succinylase
- substituent
- Prior art date
Links
- 0 *C(C(O)=O)NC(CCC(O)=O)=O Chemical compound *C(C(O)=O)NC(CCC(O)=O)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/222—Phenylalanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/007—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving acyl derivatives of racemic amines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Definitions
- the present invention combines 1) the reaction of racemizing an N-succinyl amino acid with an N-acylamino acid racemase, and 2) the reaction of specifically hydrolyzing an N-succinyl-L-amino acid with an L-succinylase.
- the present invention relates to a method for efficiently producing an L-amino acid from an enantiomeric mixture of N-succinyl amino acids.
- Optically active amino acids particularly optically active unnatural amino acids are useful compounds as synthetic raw materials and intermediates for agricultural chemicals, pharmaceuticals and the like. How to efficiently produce optically active amino acids, particularly unnatural amino acids, is an important industrial issue.
- racemic N-acetylamino acid is used as a raw material, and D-aminoacylase or L-aminoacylase is used to optically resolve the D-form or L-form to obtain an amino acid with high optical purity.
- D-aminoacylase or L-aminoacylase is used to optically resolve the D-form or L-form to obtain an amino acid with high optical purity.
- pattern document 1 There is a method to acquire (patent document 1). In this method, the maximum yield of optically active amino acid is 50%, and half of the racemate is wasted. Thus, attempts have been made to improve the yield by combining aminoacylase with N-acylamino acid racemase that racemizes the remaining N-acetylamino acid.
- N-acylamino acid racemase has low reactivity with N-acylamino acids (Non-Patent Documents 1 and 2 and Patent Document 6). Have also been reported to be more reactive with N-succinylamino acids (Non-patent Documents 1 and 2 and Patent Document 6). Furthermore, it has also been reported that L-succinylase acts on the N-succinyl form of natural L-amino acids (Non-patent Documents 1 and 2 and Patent Document 6). However, there is no known method for efficiently producing L-amino acids from an enantiomeric mixture of N-succinyl-amino acids by combining N-acylamino acid racemase and L-succinylase.
- R 1 may have a substituent, an alkyl group having 5 to 20 carbon atoms, an optionally substituted alkenyl group having 5 to 20 carbon atoms, or a substituent.
- the N-succinyl amino acid represented by the above formula or a salt thereof has not been known so far.
- JP 2006-254789 A Japanese Patent Laid-Open No. 2001-46088 JP 2001-314191 A Japanese Patent Laid-Open No. 2002-238581 JP 2007-82534 A JP 2008-61642 A
- An object of the present invention is to provide an L-amino acid production method that is more efficient than the conventional method.
- the present inventors have conducted a reaction of racemizing N-succinylamino acid using N-acylamino acid racemase, and N-succinyl-L-amino acid using L-succinylase.
- the present inventors have found that the reactivity can be improved by precipitating the produced amino acid out of the reaction system during the reaction in which the reaction of specifically hydrolyzing is combined, and the present invention has been completed.
- the present invention relates to a method for producing an L-amino acid by allowing an L-succinylase to act on an enantiomeric mixture of N-succinylamino acids, wherein the produced L-amino acid is precipitated in the presence of N-acylamino acid racemase.
- the dissolution concentration of the L-amino acid is preferably 1% by weight or less.
- the substrate N-succinylamino acid is represented by the general formula (I);
- R may have an optionally substituted alkyl group having 1 to 20 carbon atoms, an optionally substituted alkenyl group having 2 to 20 carbon atoms, or an optionally substituted group.
- the produced L-amino acid is represented by the general formula (II);
- R in the above formulas (I) and (II) is a 4-bromobenzyl group, a 3-fluorobenzyl group, a naphthylmethyl group, an indanyl group, or a 6-heptenyl group.
- a transformant transformed with a vector containing a DNA encoding N-acylamino acid racemase and a DNA encoding L-succinylase as N-acylamino acid racemase and L-succinylase is used. use.
- the present invention also relates to a general formula (III);
- R 1 may have a substituent, an alkyl group having 5 to 20 carbon atoms, an optionally substituted alkenyl group having 5 to 20 carbon atoms, or a substituent.
- R in the above formula (III) is a 4-bromobenzyl group, a 3-fluorobenzyl group, a 2-naphthylmethyl group, a 2-indanyl group, or a 6-heptenyl group.
- the “enantiomeric mixture” of the present invention is a mixture of L-form and D-form containing D-form in a range of more than 0% to less than 100%.
- the N-succinyl amino acid that is the raw material of the present invention has the general formula (I);
- R has an optionally substituted alkyl group having 1 to 20 carbon atoms, an optionally substituted alkenyl group having 2 to 20 carbon atoms, and a substituent.
- the alkyl group having 1 to 20 carbon atoms may be linear or branched.
- alkenyl group having 2 to 20 carbon atoms include ethenyl group, propenyl group, butenyl group, pentenyl group, hexenyl group, heptenyl group, octenyl group and the like.
- alkynyl group having 2 to 20 carbon atoms examples include ethynyl group, propynyl group, butynyl group, pentynyl group, hexynyl group, heptynyl group, octynyl group and the like.
- aryl group having 4 to 20 carbon atoms examples include phenyl group, naphthyl group, anthranyl group, pyridyl group, pyrimidyl group, indanyl group, and indenyl group.
- Examples of the aralkyl group having 5 to 20 carbon atoms include benzyl group, naphthylmethyl group, anthranylmethyl group, pyridylmethyl group, pyrimidylmethyl group, indanylmethyl group, and indenylmethyl group.
- the alkyl group, alkenyl group, alkynyl group, aryl group and aralkyl group may have a substituent, and examples of the substituent include a halogen atom, a hydroxyl group, an amino group, and a nitro group.
- N-succinyl amino acid represented by the formula (I) include N-succinyl-DL-4-bromophenylalanine, N-succinyl-DL-3-fluorophenylalanine, N-succinyl-DL-2- Examples include naphthylalanine, N-succinyl-DL-2-indanylglycine, N-succinyl-DL-6-heptenylglycine, and the like.
- the L-succinylase used in the present invention is an enzyme that selectively hydrolyzes (desuccinylates) the succinyl group of the N-succinyl amino acid represented by the general formula (I), and includes N-acyl amino acid racemase and Is an enzyme that racemizes the enantiomer of the N-succinyl amino acid represented by the general formula (I).
- the enantiomeric mixture of N-succinyl amino acids can be converted into an L-amino acid consisting essentially of a single enantiomer. Furthermore, in a preferred embodiment of the present invention, when the accumulated concentration of L-amino acid after the reaction process or after completion of the reaction is higher than the dissolved concentration, L-amino acid is precipitated out of the reaction system, and the reaction proceeds efficiently.
- D-succinylase D-form selective desuccinylation
- an enantiomeric mixture of N-succinyl amino acids consists essentially of a single enantiomer by applying the above principle of the present invention. It can be efficiently converted to D-amino acid.
- D-aminoacylase is known as an enzyme that selectively hydrolyzes N-succinylamino acid in D form (Japanese Patent Laid-Open No. 2008-61642), it has not been shown that practical activity has been obtained.
- the dissolution concentration is the weight percent of amino acids that can be dissolved in the reaction solution after completion of the reaction, and can be measured by the method described below.
- L-amino acid is added until it is no longer soluble in the reaction solution after completion of the reaction, and then centrifuged.
- the resulting amino acid in the solution obtained by filtering the supernatant is subjected to quantitative analysis by high performance liquid chromatography and calculated.
- the weight% of the produced amino acid (including the precipitated produced amino acid and the dissolved produced amino acid) in the reaction solution after completion of the reaction can be measured by the method described below. After the reaction is completed, the reaction solution is sampled uniformly, including the precipitated amino acid, and the precipitated amino acid is solubilized using an appropriate solvent, and the amino acid in the solution is quantitatively analyzed by high performance liquid chromatography. ,calculate.
- the dissolution concentration is preferably 3% by weight or less, more preferably 1% by weight or less.
- L-amino acid is produced in excess of the above-mentioned dissolution concentration, L-amino acid is precipitated.
- the weight percentage of the produced amino acid in the reaction solution after the reaction is high, and preferably more than twice the dissolution concentration. More preferably, it is 5 times or more.
- the method for producing an L-amino acid of the present invention can be carried out by allowing an enantiomeric mixture of N-succinylamino acid serving as a substrate, L-succinylase and N-acylamino acid racemase to coexist in a suitable solvent.
- an aqueous solvent may be used, or an aqueous solvent and an organic solvent may be mixed and used.
- the organic solvent include toluene, ethyl acetate, n-butyl acetate, hexane, isopropanol, diisopropyl ether, methanol, acetone, dimethyl sulfoxide and the like.
- the reaction is carried out, for example, at a temperature of 10 ° C to 70 ° C, preferably 30 ° C to 55 ° C.
- the pH of the reaction solution is maintained at, for example, 4 to 10, preferably 6 to 9.
- the reaction can be carried out in batch mode or continuous mode.
- the reaction substrate is added at a feed concentration of, for example, 0.1% to 70% (w / v), preferably 3% to 50% (w / v).
- the L-amino acids produced in the reaction can be isolated and purified by conventional methods.
- the reaction solution containing the L-amino acid produced by the reaction can be isolated and purified by performing a treatment such as chromatography.
- the filtrate obtained by removing microbial cells from the reaction solution can be isolated and purified by neutralization crystallization using hydrochloric acid or the like, and the precipitated target product is filtered off.
- the filtrate which removed the microbial cell from the reaction liquid can also be used for reaction of the next process as it is.
- the N-acyl amino acid racemase used in the present invention has the ability to racemize the N-succinyl amino acid represented by the formula (I).
- Such enzymes include, but are not particularly limited, specifically, Geobacillus (Geobacillus) genus and Thermus (Thermus) genus include microbial enzymes from belonging to such, preferably, Geobacillus Kausutofirasu (Geobacillus kaustophilus) , An enzyme derived from microorganisms such as Thermus thermophilus . More preferred are enzymes derived from Geobacillus kaustophilus NBRC102445 and Thermus thermophilus HB8.
- the gene encoding the amino acid sequence of the N-acyl amino acid racemase derived from Geobacillus kaustophilus NBRC102445 is represented by SEQ ID NO: 2.
- the L-succinylase used in the present invention has the ability to hydrolyze the L form of the N-succinyl amino acid represented by the formula (I).
- Such enzymes are not particularly limited, but typical examples include enzymes derived from microorganisms belonging to the genus Geobacillus , and preferably derived from microorganisms such as Geobacillus kaustophilus. It is an enzyme. More preferably, it is an enzyme derived from Geobacillus kaustophilus NBRC102445, and the gene encoding the amino acid sequence is represented by SEQ ID NO: 1.
- microorganisms are available to those skilled in the art from various depository institutions.
- the depository organization includes an organization corresponding to a deposit number for identifying each microorganism.
- the microorganism identified by the NBRC number is available from the Biological Resource Department of the National Institute of Technology and Evaluation, 2-5-8, Kazusa Kamashi, Kisarazu City, Chiba Prefecture, Japan. It can also be separated from nature. It is also possible to obtain strains having properties more advantageous for this reaction by causing mutations in these microorganisms.
- a microorganism culture solution obtained by culturing the above-mentioned microorganism or transformant in an appropriate medium can be used as an enzyme, and a treated product of the culture can also be used.
- the treated product include a culture supernatant obtained by a collection operation such as centrifugation from a microorganism culture solution, a microorganism cell, a disrupted product of the microorganism, a cell-free extract obtained from the disrupted product, and an immobilized cell And purified purified enzymes, immobilized enzymes, and the like.
- Examples of the “host” described in the present specification include bacteria, yeasts, filamentous fungi, plant cells, animal cells, and the like, but bacteria are preferable from the introduction and expression efficiency, and Escherichia coli is particularly preferable.
- a vector containing DNA can be introduced into a host cell by a known method. When Escherichia coli is used as the host cell, the vector can be introduced into the host by using, for example, a commercially available Escherichia coli HB101 competent cell (manufactured by Takara Bio Inc.).
- vector described in the present specification is not particularly limited as long as it can express a gene encoded by DNA in an appropriate host.
- examples of such vectors include plasmid vectors, phage vectors, cosmid vectors, and shuttle vectors that can exchange genes with other host strains can also be used.
- Such vectors usually contain regulatory elements such as lacUV5 promoter, trp promoter, trc promoter, tac promoter, lpp promoter, tufB promoter, recA promoter, pL promoter, etc., and an expression unit operably linked to DNA. It can be suitably used as an expression vector.
- pUCN18 can be preferably used.
- the plasmid pUCN18 is modified by changing the 185th T of pUC18 (manufactured by Takara Bio Inc., GenBank Accession No. L09136) to A by destroying the NdeI site, and further changing the 471-472th GC to TG. This is a plasmid in which an NdeI site has been newly introduced.
- the regulatory factor refers to a base sequence having a functional promoter and any associated transcription element (eg, enhancer, CCAAT box, TATA box, SPI site, etc.).
- operably linked means that a gene is operably linked to various regulatory elements such as promoters and enhancers that regulate the expression of the gene. It is well known to those skilled in the art that the type and kind of the control factor can vary depending on the host.
- the “transformant” described in the present specification is obtained by incorporating a DNA encoding a polypeptide into a vector and introducing it into a host cell.
- the “transformant” described in this specification includes not only cultured cells but also processed products thereof.
- the treated product as used herein means, for example, a cell treated with a surfactant or an organic solvent, a dried cell, a disrupted cell, a crude cell extract or the like, and those immobilized by a known means. To do.
- the culture of the transformant described in the present specification can be performed using a normal liquid nutrient medium containing a carbon source, a nitrogen source, inorganic salts, organic nutrients and the like as long as it grows.
- both a DNA encoding an N-acylamino acid racemase and a DNA encoding an L-succinylase are introduced, and a trait having the activities of both N-acylamino acid racemase and L-succinylase is introduced.
- a converter can also be used. If such a transformant is used, it is not necessary to prepare N-acylamino acid racemase and L-succinylase separately, and the production method of the present invention can be carried out more easily.
- the transformant containing both the DNA encoding the N-acylamino acid racemase and the DNA encoding the L-succinylase of the present invention is the same in both the DNA encoding the N-acylamino acid racemase and the DNA encoding the L-succinylase.
- these two types of DNA are incorporated into two different vectors of different incompatibility groups, and these two types of vectors are introduced into the same host cell. Can also be obtained.
- Examples of transformants containing both the DNA encoding the N-acyl amino acid racemase and the DNA encoding L-succinylase of the present invention include E. coli HB101 (pNIGHK).
- % means “% by weight” unless otherwise specified.
- the recombination vector pNHK was constructed by inserting the second GC into a TG and inserting it between the EcoRI recognition site and the BamHI recognition site downstream of the lac promoter of the plasmid into which the NdeI site was newly introduced.
- E. E. coli HB101 competent cells Takara Bio Inc.
- coli HB101 pNHK
- the obtained transformant was inoculated into 5 ml of 2 ⁇ YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 ⁇ g / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours. The cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0). This was crushed using a UH-50 type ultrasonic homogenizer (manufactured by SMT), and then the cell residue was removed by centrifugation to obtain a cell-free extract. The succinylase activity of this cell-free extract was measured, and the expression of 5 U succinylase activity was observed.
- coli HB101 (pNIG) was obtained.
- the obtained transformant was inoculated into 5 ml of 2 ⁇ YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 ⁇ g / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours. The cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0). This was crushed using a UH-50 type ultrasonic homogenizer (manufactured by SMT), and then the cell residue was removed by centrifugation to obtain a cell-free extract.
- the cell-free extract was assayed for N-acyl amino acid racemase activity, and the expression of N-acyl amino acid racemase activity 2U was observed.
- a gene obtained by adding an NdeI recognition site and an EcoRI recognition site to the N-acylamino acid racemase gene (SEQ ID NO: 3) derived from Thermus thermophilus HB8 strain was obtained by PCR using DNA polymerase PrimeSTAR (Takara Shuzo). The DNA fragment obtained by the above PCR was inserted between the NdeI recognition site and EcoRI recognition site downstream of the lac promoter of the plasmid pUCN18 to construct a recombinant vector pNIT. Using the recombinant vector pNIT, E. E.
- coli HB101 competent cells (Takara Bio Inc.) coli HB101 (pNIT) was obtained.
- the obtained transformant was inoculated into 5 ml of 2 ⁇ YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 ⁇ g / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours.
- the cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0). This was crushed using a UH-50 type ultrasonic homogenizer (manufactured by SMT), and then the cell residue was removed by centrifugation to obtain a cell-free extract.
- the cell-free extract was assayed for N-acyl amino acid racemase activity, and expression of N-acyl amino acid racemase activity 1U was observed.
- the racemase activity of N-acylamino acid racemase was measured by the method described below.
- the substrate N-acetyl-D-methionine solution 100 ⁇ l (final concentration 20 mM), cobalt chloride aqueous solution 5 ⁇ l (final concentration 1 mM), Tris-HCl (0.5 M / pH 7.5) 50 ⁇ l (final concentration 50 mM), 245 ⁇ l of sterilized distilled water was mixed, and 50 ⁇ l of L-aminoacylase solution (20 mg / ml, N-acetyl-L-methionine produced by racemase is deacylated to produce L-methionine) in this reaction solution, and enzyme solution 50 ⁇ l was added and the reaction was carried out at 30 ° C., and the reaction was stopped by adding 1N HCl at an appropriate time.
- the produced L-methionine is quantified by high performance liquid chromatography, and the enzyme activity is calculated.
- the enzyme activity was defined as 1 unit (U) when 1 ⁇ mole of N-acetyl-L-methionine was produced from N-acetyl-D-methionine per minute.
- Example 1 Production of L-4- bromophenylalanine 2.2 g of DL-4-bromophenylalanine, 0.99 g of succinic anhydride and 20 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and crystallized with ethyl acetate. Analysis was performed to obtain 2.1 g of N-succinyl-DL-4-bromophenylalanine. N- succinyl -DL-4-bromo-phenylalanine substrate solution (pH 8) was prepared and after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E.
- Example 2 Production of L-3 -fluorophenylalanine 2.0 g of DL-3-fluorophenylalanine, 0.99 g of succinic anhydride and 20 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and then crystallized with ethyl acetate. Analysis was performed to obtain 1.9 g of N-succinyl-DL-3-fluorophenylalanine. N- succinyl -DL-3- fluorophenylalanine substrate solution (pH 8) was prepared, after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E.
- N- succinyl -DL-2-naphthylalanine of substrate solution (pH 8) was prepared, after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E. coli HB101 (pNHK) and E. When the culture solution of E. coli HB101 (pNIG) was mixed (final substrate concentration was 9% by weight) and the reaction was carried out at 45 ° C., 2-naphthylalanine was precipitated in the reaction solution. After stirring for 20 hours, the conversion rate (mol%) and optical purity (% ee) were determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography.
- the optical purity of L-2-naphthylalanine is 100% e.e. e. Met.
- the accumulated concentration of L-2-naphthylalanine calculated from the conversion rate was 6.2% by weight. Further, when the dissolved concentration of L-2-naphthylalanine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.2 wt% or less.
- Example 4 Production of L-2-indanylglycine 2.5 g of DL-2-indanylglycine, 1.44 g of succinic anhydride and 30 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and then ethyl acetate was added. Crystallization of N-succinyl-DL-2-indanylglycine (3.2 g) was obtained. N- succinyl -DL-2-indanylglycine of substrate solution (pH 8) was prepared, after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 11 and Reference Example 3 E. E.
- Example 5 Production of L-6-heptenylglycine 2.0 g of DL-6-heptenylglycine, 1.29 g of succinic anhydride and 20 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and then ethyl acetate was added. Was obtained, and 1.4 g of N-succinyl-DL-6-heptenylglycine was obtained.
- N- succinyl -DL-6- heptenyl glycine substrate solution (pH 8) was prepared and after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E.
- the accumulated concentration of L-6-heptenylglycine calculated from the conversion rate was 5.7% by weight. Further, when the dissolved concentration of L-6-heptenylglycine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.5% by weight or less.
- the culture solution of E. coli HB101 (pNIG) was mixed (final substrate concentration was 6% by weight), and the reaction was carried out at 45 ° C. After stirring for 21 hours, the conversion rate (mol%) and optical purity (% ee) were determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. As a result, the conversion rate was 86. 0.0 mol%, the optical purity of L-phenylalanine is 100% e.e. e. Met. The accumulated concentration of L-phenylalanine calculated from the conversion rate was 3.2% by weight. The dissolved concentration of L-phenylalanine was quantitatively analyzed and measured by high performance liquid chromatography and found to be 4% by weight.
- Example 6 Preparation of transformant transformed with vector containing L-succinylase and N-acylamino acid racemase gene
- SEQ ID NO: 1 derived from Geobacillus caustophilus NBRC102445 strain
- a gene obtained by adding a SacI recognition site and a BamHI recognition site to a gene modified to G was obtained by PCR using DNA polymerase PrimeSTAR (Takara Shuzo).
- the DNA fragment obtained by the above PCR was inserted between the SacI recognition site and the BamHI recognition site of the plasmid pNIG prepared in Reference Example 3 to construct a recombinant vector pNIGHK.
- E. E. coli HB101 competent cells manufactured by Takara Bio Inc.
- E. coli HB101 (pNIGHK) was obtained.
- the obtained transformant was inoculated into 5 ml of 2 ⁇ YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 ⁇ g / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours. The cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0).
- Example 7 Production of L-6-heptenylglycine using a transformant transformed with a vector containing L-succinylase and N-acylamino acid racemase gene N-succinyl-DL in the same manner as in Example 5.
- a substrate solution (pH 8) of -6-heptenylglycine was prepared, and an aqueous cobalt chloride solution was added to a final concentration of 1 mM, followed by culturing in the same manner as in Example 6 .
- a culture solution of E. coli HB101 pNIGHK
- 6-heptenylglycine was precipitated in the reaction solution.
- the conversion rate (mol%) was determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. As a result, the conversion rate was 99.6 mol%. Further, the product was derivatized with di-tert-butyl dicarbonate to N-tert-butoxycarbonyl 6-heptenylglycine, and optical purity (% ee) analysis was performed by high performance liquid chromatography. . e. Met. The accumulated concentration of L-6-heptenylglycine calculated from the conversion rate was 5.7% by weight. Further, when the dissolved concentration of L-6-heptenylglycine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.5% by weight or less.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
1)アミノ酸及びアミノ酸と当量以上の無水コハク酸を酢酸中で反応後、溶媒留去を行い、酢酸エチル・メタノール中で再結晶させる方法
2)アミノ酸及びアミノ酸と当量以上の無水コハク酸を水中でpHをアルカリ側に保ちながら反応後、pHを酸性にして結晶として析出させる方法、
等によって取得できる。 It can be synthesized by various known methods. For example,
1) A method in which an amino acid and an amino acid and an equivalent amount or more of succinic anhydride are reacted in acetic acid, followed by distilling off the solvent and recrystallization in ethyl acetate / methanol. After the reaction while maintaining the pH on the alkali side, the pH is acidified and precipitated as crystals,
Can be obtained by etc.
ゲオバチルス・カウストフィラス(Geobacillus kaustophilus)NBRC102445株由来のL-サクシニラーゼ遺伝子(配列番号1)にEcoRI認識部位とBamHI認識部位を付加した遺伝子を、DNAポリメラーゼPrimeSTAR(宝酒造社製)を用いたPCRを行い取得した。上記のPCRで得られたDNA断片をプラスミドpUCN18(PCR法によりpUC18(タカラバイオ社製、GenBank Accession No. L09136)の185番目のTをAに改変してNdeIサイトを破壊し、更に471-472番目のGCをTGに改変することにより新たにNdeIサイトを導入したプラスミド)のlacプロモーターの下流のEcoRI認識部位とBamHI認識部位の間に挿入し、組換えベクターpNHKを構築した。組換えベクターpNHKを用いて、E.coli HB101コンピテントセル(タカラバイオ社製)を形質転換し、E.coli HB101(pNHK)を得た。得られた形質転換体を、200μg/mlのアンピシリンを含む2×YT培地(トリプトン1.6%、イーストエキス1.0%、NaCl0.5%、pH7.0)5mlに接種し、37℃で24時間振盪培養した。遠心分離により菌体を集め、5mlの100mMリン酸緩衝液(pH7.0)に懸濁した。これを、UH-50型超音波ホモゲナイザー(SMT社製)を用いて破砕した後、遠心分離により菌体残渣を除去し、無細胞抽出液を得た。この無細胞抽出液のサクシニラーゼ活性を測定し、サクシニラーゼ活性5Uの発現が認められた。 (Reference Example 1) Preparation of L-succinylase A gene obtained by adding an EcoRI recognition site and a BamHI recognition site to an L-succinylase gene (SEQ ID NO: 1) derived from Geobacillus kaustophilus NBRC102445 strain was added to DNA polymerase PrimeSTAR (Takara Shuzo Co., Ltd.). Obtained by PCR. The DNA fragment obtained by the above PCR was changed to the plasmid pUCN18 (by PCR, the 185th T of pUC18 (manufactured by Takara Bio Inc., GenBank Accession No. L09136) was changed to A to destroy the NdeI site, and 471-472 The recombination vector pNHK was constructed by inserting the second GC into a TG and inserting it between the EcoRI recognition site and the BamHI recognition site downstream of the lac promoter of the plasmid into which the NdeI site was newly introduced. Using the recombinant vector pNHK, E. E. coli HB101 competent cells (Takara Bio Inc.) coli HB101 (pNHK) was obtained. The obtained transformant was inoculated into 5 ml of 2 × YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 μg / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours. The cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0). This was crushed using a UH-50 type ultrasonic homogenizer (manufactured by SMT), and then the cell residue was removed by centrifugation to obtain a cell-free extract. The succinylase activity of this cell-free extract was measured, and the expression of 5 U succinylase activity was observed.
L-サクシニラーゼのサクシニラーゼ活性は以下に述べる方法で測定した。基質となるN-サクシニル-DL-フェニルアラニン溶液250μl(終濃度50mM)、Tris-HCl(0.5M/pH7.5)230μlを混和し、この反応液に酵素液20μlを加えて30℃で反応を行い、適当な時間で1N HCl添加により反応停止させた。生成したL-フェニルアラニンを高速液体クロマトグラフィーにより定量し、酵素活性を算出した。酵素活性はN-サクシニル-DL-フェニルアラニンからL-フェニルアラニンが1分間に1μmole生成された場合を1unit(U)と定義した。 Reference Example 2 Measurement of L-succinylase activity The succinylase activity of L-succinylase was measured by the method described below. Mix 250 μl of N-succinyl-DL-phenylalanine solution (final concentration 50 mM) and 230 μl of Tris-HCl (0.5 M / pH 7.5) as a substrate, add 20 μl of enzyme solution to this reaction solution, and react at 30 ° C. The reaction was stopped at the appropriate time by addition of 1N HCl. The produced L-phenylalanine was quantified by high performance liquid chromatography, and the enzyme activity was calculated. The enzyme activity was defined as 1 unit (U) when 1 μmole of L-phenylalanine was produced from N-succinyl-DL-phenylalanine per minute.
ゲオバチルス・カウストフィラスNBRC102445株由来のN-アシルアミノ酸ラセマーゼ遺伝子(配列番号2)にEcoRI認識部位とSacI認識部位を付加した遺伝子を、DNAポリメラーゼPrimeSTAR(宝酒造社製)を用いたPCRを行い取得した。上記のPCRで得られたDNA断片をプラスミドpUCN18のlacプロモーターの下流のEcoRI認識部位とSacI認識部位の間に挿入し、組換えベクターpNIGを構築した。組換えベクターpNIGを用いて、E.coli HB101コンピテントセル(タカラバイオ社製)を形質転換し、E.coli HB101(pNIG)を得た。得られた形質転換体を、200μg/mlのアンピシリンを含む2×YT培地(トリプトン1.6%、イーストエキス1.0%、NaCl0.5%、pH7.0)5mlに接種し、37℃で24時間振盪培養した。遠心分離により菌体を集め、5mlの100mMリン酸緩衝液(pH7.0)に懸濁した。これを、UH-50型超音波ホモゲナイザー(SMT社製)を用いて破砕した後、遠心分離により菌体残渣を除去し、無細胞抽出液を得た。この無細胞抽出液のN-アシルアミノ酸ラセマーゼ活性を測定し、N-アシルアミノ酸ラセマーゼ活性2Uの発現が認められた。 サーマス・サーモフィラスHB8株由来のN-アシルアミノ酸ラセマーゼ遺伝子(配列番号3)にNdeI認識部位とEcoRI認識部位を付加した遺伝子を、DNAポリメラーゼPrimeSTAR(宝酒造社製)を用いたPCRを行い取得した。上記のPCRで得られたDNA断片をプラスミドpUCN18のlacプロモーターの下流のNdeI認識部位とEcoRI認識部位の間に挿入し、組換えベクターpNITを構築した。組換えベクターpNITを用いて、E.coli HB101コンピテントセル(タカラバイオ社製)を形質転換し、E.coli HB101(pNIT)を得た。得られた形質転換体を、200μg/mlのアンピシリンを含む2×YT培地(トリプトン1.6%、イーストエキス1.0%、NaCl0.5%、pH7.0)5mlに接種し、37℃で24時間振盪培養した。遠心分離により菌体を集め、5mlの100mMリン酸緩衝液(pH7.0)に懸濁した。これを、UH-50型超音波ホモゲナイザー(SMT社製)を用いて破砕した後、遠心分離により菌体残渣を除去し、無細胞抽出液を得た。この無細胞抽出液のN-アシルアミノ酸ラセマーゼ活性を測定し、N-アシルアミノ酸ラセマーゼ活性1Uの発現が認められた。 (Reference Example 3) Preparation of N-acylamino acid racemase A gene obtained by adding an EcoRI recognition site and a SacI recognition site to the N-acylamino acid racemase gene (SEQ ID NO: 2) derived from Geobacillus caustophilus NBRC102445 strain was added to DNA polymerase PrimeSTAR (Takara Shuzo). Obtained by PCR. The DNA fragment obtained by the above PCR was inserted between the EcoRI recognition site and the SacI recognition site downstream of the lac promoter of the plasmid pUCN18 to construct a recombinant vector pNIG. Using the recombinant vector pNIG, E. E. coli HB101 competent cells (Takara Bio Inc.) E. coli HB101 (pNIG) was obtained. The obtained transformant was inoculated into 5 ml of 2 × YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 μg / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours. The cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0). This was crushed using a UH-50 type ultrasonic homogenizer (manufactured by SMT), and then the cell residue was removed by centrifugation to obtain a cell-free extract. The cell-free extract was assayed for N-acyl amino acid racemase activity, and the expression of N-acyl amino acid racemase activity 2U was observed. A gene obtained by adding an NdeI recognition site and an EcoRI recognition site to the N-acylamino acid racemase gene (SEQ ID NO: 3) derived from Thermus thermophilus HB8 strain was obtained by PCR using DNA polymerase PrimeSTAR (Takara Shuzo). The DNA fragment obtained by the above PCR was inserted between the NdeI recognition site and EcoRI recognition site downstream of the lac promoter of the plasmid pUCN18 to construct a recombinant vector pNIT. Using the recombinant vector pNIT, E. E. coli HB101 competent cells (Takara Bio Inc.) coli HB101 (pNIT) was obtained. The obtained transformant was inoculated into 5 ml of 2 × YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 μg / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours. The cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0). This was crushed using a UH-50 type ultrasonic homogenizer (manufactured by SMT), and then the cell residue was removed by centrifugation to obtain a cell-free extract. The cell-free extract was assayed for N-acyl amino acid racemase activity, and expression of N-acyl amino acid racemase activity 1U was observed.
N-アシルアミノ酸ラセマーゼのラセマーゼ活性は以下に述べる方法で測定した。基質となるN-アセチル-D-メチオニン溶液を100μl(終濃度20mM)、塩化コバルト水溶液を5μl(終濃度1mM)、Tris-HCl(0.5M/pH7.5)を50μl(終濃度50mM)、滅菌蒸留水を245μlを混和し、この反応液にL-アミノアシラーゼ溶液(20mg/ml、ラセマーゼによって生成するN-アセチル-L-メチオニンを脱アシル化しL-メチオニンを生成する)50μl、及び酵素液50μlを加えて30℃で反応を行い、適当な時間で1N HCl添加により反応停止させた。生成したL-メチオニンを高速液体クロマトグラフィーにより定量し、酵素活性を算出する。酵素活性はN-アセチル-D-メチオニンからN-アセチル-L-メチオニンが1分間に1μmole生成された場合を1unit(U)と定義した。 (Reference Example 4) Measurement of activity of N-acylamino acid racemase The racemase activity of N-acylamino acid racemase was measured by the method described below. The substrate N-acetyl-D-methionine solution 100 μl (final concentration 20 mM), cobalt chloride aqueous solution 5 μl (final concentration 1 mM), Tris-HCl (0.5 M / pH 7.5) 50 μl (final concentration 50 mM), 245 μl of sterilized distilled water was mixed, and 50 μl of L-aminoacylase solution (20 mg / ml, N-acetyl-L-methionine produced by racemase is deacylated to produce L-methionine) in this reaction solution, and enzyme solution 50 μl was added and the reaction was carried out at 30 ° C., and the reaction was stopped by adding 1N HCl at an appropriate time. The produced L-methionine is quantified by high performance liquid chromatography, and the enzyme activity is calculated. The enzyme activity was defined as 1 unit (U) when 1 μmole of N-acetyl-L-methionine was produced from N-acetyl-D-methionine per minute.
DL-4-ブロモフェニルアラニン2.2gと無水コハク酸0.99g及び酢酸20mlを混合し、55℃で4h反応させ、濃縮後酢酸エチルでの晶析を行い、N-サクシニル-DL-4-ブロモフェニルアラニン2.1gを取得した。N-サクシニル-DL-4-ブロモフェニルアラニンの基質溶液(pH8)を調製し、塩化コバルト水溶液を終濃度1mMとなるように添加後、参考例1及び参考例3と同様に培養したE.coli HB101(pNHK)及びE.coli HB101(pNIG)の培養液を混合し(基質の終濃度は8重量%)、45℃にて反応を行ったところ、反応液中に4-ブロモフェニルアラニンが析出した。18時間攪拌後、反応液中の基質及び生成物を高速液体クロマトグラフィーにて分析することにより、変換率(mol%)及び光学純度(%e.e.)を求めた結果、変換率は98.0mol%、L-4-ブロモフェニルアラニンの光学純度は100%e.e.であった。変換率より算出されるL-4-ブロモフェニルアラニンの蓄積濃度は5.5重量%であった。また、L-4-ブロモフェニルアラニンの溶解濃度を高速液体クロマトグラフィーにて定量分析測定したところ、0.5重量%以下であった。 Example 1 Production of L-4- bromophenylalanine 2.2 g of DL-4-bromophenylalanine, 0.99 g of succinic anhydride and 20 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and crystallized with ethyl acetate. Analysis was performed to obtain 2.1 g of N-succinyl-DL-4-bromophenylalanine. N- succinyl -DL-4-bromo-phenylalanine substrate solution (pH 8) was prepared and after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E. coli HB101 (pNHK) and E. coli . When the culture solution of E. coli HB101 (pNIG) was mixed (final concentration of the substrate was 8% by weight) and reacted at 45 ° C., 4-bromophenylalanine was precipitated in the reaction solution. After stirring for 18 hours, the conversion rate (mol%) and optical purity (% ee) were determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. 0.0 mol%, the optical purity of L-4-bromophenylalanine is 100% e.e. e. Met. The accumulated concentration of L-4-bromophenylalanine calculated from the conversion rate was 5.5% by weight. Further, when the dissolved concentration of L-4-bromophenylalanine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.5% by weight or less.
光学純度(%e.e.)=(A-B)/(A+B)×100(Aは対象とする鏡像異性体量でBは対応する鏡像異性体量)
<高速液体クロマトグラフィー分析条件>
[変換率の分析]
カラム:COSMOSIL 5C18-AR-II
(4.6mmφ×250mm、ナカライ社製)
溶離液:20mM リン酸水溶液(pH2.5)/アセトニトリル=8/2
流速:1.0ml/分
カラム温度:30℃
測定波長:210nm
[光学純度の分析]
カラム:CROWNPAC CR(+)(4.6mmφ×150mm、ダイセル社製)
溶離液:過塩素酸水溶液(pH1.5)/メタノール=85/15
流速:1.0ml/分
カラム温度:30℃
測定波長:210nm。 Conversion rate (mol%) = product amount / (residual base mass + product amount) × 100
Optical purity (% ee) = (A−B) / (A + B) × 100 (A is the amount of the enantiomer of interest and B is the amount of the corresponding enantiomer)
<High-performance liquid chromatography analysis conditions>
[Conversion rate analysis]
Column: COSMOSIL 5C18-AR-II
(4.6 mmφ x 250 mm, manufactured by Nacalai)
Eluent: 20 mM phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 8/2
Flow rate: 1.0 ml / min Column temperature: 30 ° C
Measurement wavelength: 210 nm
[Analysis of optical purity]
Column: CROWNPAC CR (+) (4.6 mmφ × 150 mm, manufactured by Daicel)
Eluent: Perchloric acid aqueous solution (pH 1.5) / methanol = 85/15
Flow rate: 1.0 ml / min Column temperature: 30 ° C
Measurement wavelength: 210 nm.
DL-3-フルオロフェニルアラニン2.0gと無水コハク酸0.99g及び酢酸20mlを混合し、55℃で4h反応させ、濃縮後酢酸エチルでの晶析を行い、N-サクシニル-DL-3-フルオロフェニルアラニン1.9gを取得した。N-サクシニル-DL-3-フルオロフェニルアラニンの基質溶液(pH8)を調製し、塩化コバルト水溶液を終濃度1mMとなるように添加後、参考例1及び参考例3と同様に培養したE.coli HB101(pNHK)及びE.coli HB101(pNIG)の培養液を混合し(基質の終濃度は8重量%)、45℃にて反応を行ったところ、反応液中に3-フルオロフェニルアラニンが析出した。20時間攪拌後、反応液中の基質及び生成物を高速液体クロマトグラフィーにて分析することにより、変換率(mol%)及び光学純度(%e.e.)を求めた結果、変換率は97.5mol%、L-3-フルオロフェニルアラニンの光学純度は100%e.e.であった。変換率より算出されるL-3-フルオロフェニルアラニンの蓄積濃度は5.1重量%であった。また、L-3-フルオロフェニルアラニンの溶解濃度を高速液体クロマトグラフィーにて定量分析測定したところ、0.5重量%以下であった。 Example 2 Production of L-3 -fluorophenylalanine 2.0 g of DL-3-fluorophenylalanine, 0.99 g of succinic anhydride and 20 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and then crystallized with ethyl acetate. Analysis was performed to obtain 1.9 g of N-succinyl-DL-3-fluorophenylalanine. N- succinyl -DL-3- fluorophenylalanine substrate solution (pH 8) was prepared, after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E. coli HB101 (pNHK) and E. When a culture solution of E. coli HB101 (pNIG) was mixed (the final concentration of the substrate was 8% by weight) and the reaction was performed at 45 ° C., 3-fluorophenylalanine was precipitated in the reaction solution. After stirring for 20 hours, the conversion rate (mol%) and optical purity (% ee) were determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. 0.5 mol%, the optical purity of L-3-fluorophenylalanine is 100% e.e. e. Met. The accumulated concentration of L-3-fluorophenylalanine calculated from the conversion rate was 5.1% by weight. Further, when the dissolved concentration of L-3-fluorophenylalanine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.5 wt% or less.
光学純度(%e.e.)=(A-B)/(A+B)×100(Aは対象とする鏡像異性体量でBは対応する鏡像異性体量)
<高速液体クロマトグラフィー分析条件>
[変換率の分析]
カラム:COSMOSIL 5C18-AR-II
(4.6mmφ×250mm、ナカライ社製)
溶離液:20mM リン酸水溶液(pH2.5)/アセトニトリル=8/2
流速:1.0ml/分
カラム温度:30℃
測定波長:210nm
[光学純度の分析]
カラム:CROWNPAC CR(+)(4.6mmφ×150mm、ダイセル社製)
溶離液:過塩素酸水溶液(pH1.5)/メタノール=85/15
流速:1.0ml/分
カラム温度:30℃
測定波長:210nm。 Conversion rate (mol%) = product amount / (residual base mass + product amount) × 100
Optical purity (% ee) = (A−B) / (A + B) × 100 (A is the amount of the enantiomer of interest and B is the amount of the corresponding enantiomer)
<High-performance liquid chromatography analysis conditions>
[Conversion rate analysis]
Column: COSMOSIL 5C18-AR-II
(4.6 mmφ x 250 mm, manufactured by Nacalai)
Eluent: 20 mM phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 8/2
Flow rate: 1.0 ml / min Column temperature: 30 ° C
Measurement wavelength: 210 nm
[Analysis of optical purity]
Column: CROWNPAC CR (+) (4.6 mmφ × 150 mm, manufactured by Daicel)
Eluent: Perchloric acid aqueous solution (pH 1.5) / methanol = 85/15
Flow rate: 1.0 ml / min Column temperature: 30 ° C
Measurement wavelength: 210 nm.
DL-2-ナフチルアラニン2.0gと無水コハク酸1.02g及び酢酸25mlを混合し、55℃で4h反応させ、濃縮後酢酸エチルでの晶析を行い、N-サクシニル-DL-2-ナフチルアラニン2.3gを取得した。N-サクシニル-DL-2-ナフチルアラニンの基質溶液(pH8)を調製し、塩化コバルト水溶液を終濃度1mMとなるように添加後、参考例1及び参考例3と同様に培養したE.coli HB101(pNHK)及びE.coli HB101(pNIG)の培養液を混合し(基質の終濃度は9重量%)、45℃にて反応を行ったところ、反応液中に2-ナフチルアラニンが析出した。20時間攪拌後、反応液中の基質及び生成物を高速液体クロマトグラフィーにて分析することにより、変換率(mol%)及び光学純度(%e.e.)を求めた結果、変換率は99.8mol%、L-2-ナフチルアラニンの光学純度は100%e.e.であった。変換率より算出されるL-2-ナフチルアラニンの蓄積濃度は6.2重量%であった。また、L-2-ナフチルアラニンの溶解濃度を高速液体クロマトグラフィーにて定量分析測定したところ、0.2重量%以下であった。 (Example 3) Production of L-2 -naphthylalanine 2.0 g of DL-2-naphthylalanine, 1.02 g of succinic anhydride and 25 ml of acetic acid were mixed, reacted at 55 ° C. for 4 hours, concentrated and crystallized with ethyl acetate. Analysis was performed to obtain 2.3 g of N-succinyl-DL-2-naphthylalanine. N- succinyl -DL-2-naphthylalanine of substrate solution (pH 8) was prepared, after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E. coli HB101 (pNHK) and E. When the culture solution of E. coli HB101 (pNIG) was mixed (final substrate concentration was 9% by weight) and the reaction was carried out at 45 ° C., 2-naphthylalanine was precipitated in the reaction solution. After stirring for 20 hours, the conversion rate (mol%) and optical purity (% ee) were determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. 8 mol%, the optical purity of L-2-naphthylalanine is 100% e.e. e. Met. The accumulated concentration of L-2-naphthylalanine calculated from the conversion rate was 6.2% by weight. Further, when the dissolved concentration of L-2-naphthylalanine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.2 wt% or less.
光学純度(%e.e.)=(A-B)/(A+B)×100(Aは対象とする鏡像異性体量でBは対応する鏡像異性体量)
<高速液体クロマトグラフィー分析条件>
[変換率の分析]
カラム:COSMOSIL 5C18-AR-II
(4.6mmφ×250mm、ナカライ社製)
溶離液:20mM リン酸水溶液(pH2.5)/アセトニトリル=8/2
流速:1.0ml/分
カラム温度:30℃
測定波長:210nm
[光学純度の分析]
カラム:CHIROBIOTIC T(4.6mmφ×250mm、Astec社製)
溶離液:水/エタノール=3/7
流速:0.5ml/分
カラム温度:40℃
測定波長:210nm。 Conversion rate (%) = product amount / (residual base mass + product amount) × 100
Optical purity (% ee) = (A−B) / (A + B) × 100 (A is the amount of the enantiomer of interest and B is the amount of the corresponding enantiomer)
<High-performance liquid chromatography analysis conditions>
[Conversion rate analysis]
Column: COSMOSIL 5C18-AR-II
(4.6 mmφ x 250 mm, manufactured by Nacalai)
Eluent: 20 mM phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 8/2
Flow rate: 1.0 ml / min Column temperature: 30 ° C
Measurement wavelength: 210 nm
[Analysis of optical purity]
Column: CHIROBIOTIC T (4.6 mmφ × 250 mm, manufactured by Astec)
Eluent: Water / ethanol = 3/7
Flow rate: 0.5 ml / min Column temperature: 40 ° C
Measurement wavelength: 210 nm.
DL-2-インダニルグリシン2.5gと無水コハク酸1.44g及び酢酸30mlを混合し、55℃で4h反応させ、濃縮後酢酸エチルでの晶析を行い、N-サクシニル-DL-2-インダニルグリシン3.2gを取得した。N-サクシニル-DL-2-インダニルグリシンの基質溶液(pH8)を調製し、塩化コバルト水溶液を終濃度1mMとなるように添加後、参考例11及び参考例3と同様に培養したE.coli HB101(pNHK)及びE.coli HB101(pNIG)の培養液を混合し(基質の終濃度は8重量%)、45℃にて反応を行ったところ、反応液中に2-インダニルグリシンが析出した。20時間攪拌後、反応液中の基質及び生成物を高速液体クロマトグラフィーにて分析することにより、変換率(mol%)及び光学純度(%e.e.)を求めた結果、変換率は100mol%、L-2-インダニルグリシンの光学純度は100%e.e.であった。変換率より算出されるL-2-インダニルグリシンの蓄積濃度は5.3重量%であった。また、L-2-インダニルグリシンの溶解濃度を高速液体クロマトグラフィーにて定量分析測定したところ、0.5重量%以下であった。 (Example 4) Production of L-2-indanylglycine 2.5 g of DL-2-indanylglycine, 1.44 g of succinic anhydride and 30 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and then ethyl acetate was added. Crystallization of N-succinyl-DL-2-indanylglycine (3.2 g) was obtained. N- succinyl -DL-2-indanylglycine of substrate solution (pH 8) was prepared, after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 11 and Reference Example 3 E. E. coli HB101 (pNHK) and E. When the culture solution of E. coli HB101 (pNIG) was mixed (final concentration of the substrate was 8% by weight) and reacted at 45 ° C., 2-indanylglycine was precipitated in the reaction solution. After stirring for 20 hours, the conversion rate (mol%) and optical purity (% ee) were determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. As a result, the conversion rate was 100 mol. %, The optical purity of L-2-indanylglycine is 100% e. e. Met. The accumulated concentration of L-2-indanylglycine calculated from the conversion rate was 5.3% by weight. Further, when the dissolved concentration of L-2-indanylglycine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.5% by weight or less.
光学純度(%e.e.)=(A-B)/(A+B)×100(Aは対象とする鏡像異性体量でBは対応する鏡像異性体量)
<高速液体クロマトグラフィー分析条件>
[変換率の分析]
カラム:COSMOSIL 5C18-AR-II
(4.6mmφ×250mm、ナカライ社製)
溶離液:20mM リン酸水溶液(pH2.5)/アセトニトリル=8/2
流速:1.0ml/分
カラム温度:30℃
測定波長:210nm
[光学純度の分析]
カラム:CROWNPAC CR(+)(4.6mmφ×150mm、ダイセル社製)
溶離液:過塩素酸水溶液(pH1.5)/メタノール=85/15
流速:1.0ml/分
カラム温度:35℃
測定波長:210nm。 Conversion rate (%) = product amount / (residual base mass + product amount) × 100
Optical purity (% ee) = (A−B) / (A + B) × 100 (A is the amount of the enantiomer of interest and B is the amount of the corresponding enantiomer)
<High-performance liquid chromatography analysis conditions>
[Conversion rate analysis]
Column: COSMOSIL 5C18-AR-II
(4.6 mmφ x 250 mm, manufactured by Nacalai)
Eluent: 20 mM phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 8/2
Flow rate: 1.0 ml / min Column temperature: 30 ° C
Measurement wavelength: 210 nm
[Analysis of optical purity]
Column: CROWNPAC CR (+) (4.6 mmφ × 150 mm, manufactured by Daicel)
Eluent: Perchloric acid aqueous solution (pH 1.5) / methanol = 85/15
Flow rate: 1.0 ml / min Column temperature: 35 ° C
Measurement wavelength: 210 nm.
DL-6-ヘプテニルグリシン2.0gと無水コハク酸1.29g及び酢酸20mlを混合し、55℃で4h反応させ、濃縮後酢酸エチルでの晶析を行い、N-サクシニル-DL-6-ヘプテニルグリシン1.4gを取得した。N-サクシニル-DL-6-ヘプテニルグリシンの基質溶液(pH8)を調製し、塩化コバルト水溶液を終濃度1mMとなるように添加後、参考例1及び参考例3と同様に培養したE.coli HB101(pNHK)及びE.coli HB101(pNIG)の培養液を混合し(基質の終濃度は9重量%)、45℃にて反応を行ったところ、反応液中に6-ヘプテニルグリシンが析出した。24時間攪拌後、反応液中の基質及び生成物を高速液体クロマトグラフィーにて分析することにより、変換率(mol%)を求めた結果、変換率は99.6mol%であった。更に生成物を二炭酸ジtert-ブチルでN-tert-ブトキシカルボニル6-ヘプテニルグリシンへと誘導化し高速液体クロマトグラフィーにて光学純度(%e.e.)分析を行ったところ、100%e.e.であった。変換率より算出されるL-6-ヘプテニルグリシンの蓄積濃度は5.7重量%であった。また、L-6-ヘプテニルグリシンの溶解濃度を高速液体クロマトグラフィーにて定量分析測定したところ、0.5重量%以下であった。
<高速液体クロマトグラフィー分析条件>
[変換率の分析]
カラム:YMC-A303(4.6mmφ×250mm、YMC社製)
溶離液:20mMリン酸水溶液(pH2.5)/アセトニトリル=1/1
流速:1.0ml/分
カラム温度:35℃
測定波長:210nm
[光学純度の分析]
カラム:CHIRALPAK AD-RH(4.6mmφ×150mm、ダイセル社製)
溶離液:0.02% リン酸水溶液(pH2.5)/アセトニトリル=65/35
流速:0.7ml/分
カラム温度:35℃
測定波長:205nm。 Example 5 Production of L-6-heptenylglycine 2.0 g of DL-6-heptenylglycine, 1.29 g of succinic anhydride and 20 ml of acetic acid were mixed, reacted at 55 ° C. for 4 h, concentrated and then ethyl acetate was added. Was obtained, and 1.4 g of N-succinyl-DL-6-heptenylglycine was obtained. N- succinyl -DL-6- heptenyl glycine substrate solution (pH 8) was prepared and after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E. coli HB101 (pNHK) and E. When the culture solution of E. coli HB101 (pNIG) was mixed (final substrate concentration was 9% by weight) and the reaction was carried out at 45 ° C., 6-heptenylglycine was precipitated in the reaction solution. After stirring for 24 hours, the conversion rate (mol%) was determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. As a result, the conversion rate was 99.6 mol%. Further, the product was derivatized with di-tert-butyl dicarbonate to N-tert-butoxycarbonyl 6-heptenylglycine, and optical purity (% ee) analysis was performed by high performance liquid chromatography. . e. Met. The accumulated concentration of L-6-heptenylglycine calculated from the conversion rate was 5.7% by weight. Further, when the dissolved concentration of L-6-heptenylglycine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.5% by weight or less.
<High-performance liquid chromatography analysis conditions>
[Conversion rate analysis]
Column: YMC-A303 (4.6 mmφ × 250 mm, manufactured by YMC)
Eluent: 20 mM phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 1/1
Flow rate: 1.0 ml / min Column temperature: 35 ° C
Measurement wavelength: 210 nm
[Analysis of optical purity]
Column: CHIRALPAK AD-RH (4.6 mmφ × 150 mm, manufactured by Daicel)
Eluent: 0.02% phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 65/35
Flow rate: 0.7 ml / min Column temperature: 35 ° C
Measurement wavelength: 205 nm.
DL-フェニルアラニン5.0gと無水コハク酸3.0g及び酢酸30mlを混合し、55℃で4h反応させ、濃縮後酢酸エチルでの晶析を行い、N-サクシニル-DL-フェニルアラニン4.5gを取得した。N-サクシニル-DL-フェニルアラニンの基質溶液(pH8)を調製し、塩化コバルト水溶液を終濃度1mMとなるように添加後、参考例1及び参考例3と同様に培養したE.coli HB101(pNHK)及びE.coli HB101(pNIG)の培養液を混合し(基質の終濃度は6重量%)、45℃にて反応を行った。21時間攪拌後、反応液中の基質及び生成物を高速液体クロマトグラフィーにて分析することにより、変換率(mol%)及び光学純度(%e.e.)を求めた結果、変換率は86.0mol%、L-フェニルアラニンの光学純度は100%e.e.であった。変換率より算出されるL-フェニルアラニンの蓄積濃度は3.2重量%であった。また、L-フェニルアラニンの溶解濃度を高速液体クロマトグラフィーにて定量分析測定したところ、4重量%であった。 (Comparative Example) Production of L-phenylalanine 5.0 g of DL -phenylalanine, 3.0 g of succinic anhydride and 30 ml of acetic acid were mixed, reacted at 55 ° C. for 4 hours, concentrated and crystallized with ethyl acetate to obtain N-succinyl. 4.5 g of -DL-phenylalanine was obtained. N- succinyl -DL- substrate solution (pH 8) and phenylalanine, after addition of aqueous solution of cobalt chloride to a final concentration of 1 mM, and cultured in the same manner as in Reference Example 1 and Reference Example 3 E. E. coli HB101 (pNHK) and E. The culture solution of E. coli HB101 (pNIG) was mixed (final substrate concentration was 6% by weight), and the reaction was carried out at 45 ° C. After stirring for 21 hours, the conversion rate (mol%) and optical purity (% ee) were determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. As a result, the conversion rate was 86. 0.0 mol%, the optical purity of L-phenylalanine is 100% e.e. e. Met. The accumulated concentration of L-phenylalanine calculated from the conversion rate was 3.2% by weight. The dissolved concentration of L-phenylalanine was quantitatively analyzed and measured by high performance liquid chromatography and found to be 4% by weight.
光学純度(%e.e.)=(A-B)/(A+B)×100(Aは対象とする鏡像異性体量でBは対応する鏡像異性体量)
<高速液体クロマトグラフィー分析条件>
[変換率の分析]
カラム:COSMOSIL 5C18-AR-II
(4.6mmφ×250mm、ナカライ社製)
溶離液:20mM リン酸水溶液(pH2.5)/アセトニトリル=8/2
流速:1.0ml/分
カラム温度:30℃
測定波長:210nm
[光学純度の分析]
カラム:CROWNPAC CR(-)(4.6mmφ×150mm、ダイセル社製)
溶離液:過塩素酸水溶液(pH2.5)
流速:1.0ml/分
カラム温度:35℃
測定波長:254nm。 Conversion rate (mol%) = product amount / (residual base mass + product amount) × 100
Optical purity (% ee) = (A−B) / (A + B) × 100 (A is the amount of the enantiomer of interest and B is the amount of the corresponding enantiomer)
<High-performance liquid chromatography analysis conditions>
[Conversion rate analysis]
Column: COSMOSIL 5C18-AR-II
(4.6 mmφ x 250 mm, manufactured by Nacalai)
Eluent: 20 mM phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 8/2
Flow rate: 1.0 ml / min Column temperature: 30 ° C
Measurement wavelength: 210 nm
[Analysis of optical purity]
Column: CROWNPAC CR (-) (4.6 mmφ × 150 mm, manufactured by Daicel)
Eluent: Perchloric acid aqueous solution (pH 2.5)
Flow rate: 1.0 ml / min Column temperature: 35 ° C
Measurement wavelength: 254 nm.
ゲオバチルス・カウストフィラスNBRC102445株由来のL-サクシニラーゼ遺伝子(配列番号1)の615番目のCをGに改変した遺伝子にSacI認識部位とBamHI認識部位を付加した遺伝子を、DNAポリメラーゼPrimeSTAR(宝酒造社製)を用いたPCRを行い取得した。上記のPCRで得られたDNA断片を参考例3で作製したプラスミドpNIGのSacI認識部位とBamHI認識部位の間に挿入し、組換えベクターpNIGHKを構築した。組換えベクターpNIGHKを用いて、E.coli HB101コンピテントセル(タカラバイオ社製)を形質転換し、E.coli HB101(pNIGHK)を得た。得られた形質転換体を、200μg/mlのアンピシリンを含む2×YT培地(トリプトン1.6%、イーストエキス1.0%、NaCl0.5%、pH7.0)5mlに接種し、37℃で24時間振盪培養した。遠心分離により菌体を集め、5mlの100mMリン酸緩衝液(pH7.0)に懸濁した。これを、UH-50型超音波ホモゲナイザー(SMT社製)を用いて破砕した後、遠心分離により菌体残渣を除去し、無細胞抽出液を得た。この無細胞抽出液のサクシニラーゼ活性及びN-アシルアミノ酸ラセマーゼ活性測定し、サクシニラーゼ活性4U及びN-アシルアミノ酸ラセマーゼ活性1Uの発現が認められた。 (Example 6) Preparation of transformant transformed with vector containing L-succinylase and N-acylamino acid racemase gene The 615th C of L-succinylase gene (SEQ ID NO: 1) derived from Geobacillus caustophilus NBRC102445 strain A gene obtained by adding a SacI recognition site and a BamHI recognition site to a gene modified to G was obtained by PCR using DNA polymerase PrimeSTAR (Takara Shuzo). The DNA fragment obtained by the above PCR was inserted between the SacI recognition site and the BamHI recognition site of the plasmid pNIG prepared in Reference Example 3 to construct a recombinant vector pNIGHK. Using a recombinant vector pNIGHK, E. E. coli HB101 competent cells (manufactured by Takara Bio Inc.) E. coli HB101 (pNIGHK) was obtained. The obtained transformant was inoculated into 5 ml of 2 × YT medium (tripton 1.6%, yeast extract 1.0%, NaCl 0.5%, pH 7.0) containing 200 μg / ml ampicillin at 37 ° C. Cultured with shaking for 24 hours. The cells were collected by centrifugation and suspended in 5 ml of 100 mM phosphate buffer (pH 7.0). This was crushed using a UH-50 type ultrasonic homogenizer (manufactured by SMT), and then the cell residue was removed by centrifugation to obtain a cell-free extract. The cell-free extract was assayed for succinylase activity and N-acylamino acid racemase activity, and expression of succinylase activity 4U and N-acylamino acid racemase activity 1U was observed.
実施例5と同様にしてN-サクシニル-DL-6-ヘプテニルグリシンの基質溶液(pH8)を調製し、塩化コバルト水溶液を終濃度1mMとなるように添加後、実施例6と同様に培養したE.coli HB101(pNIGHK)の培養液を混合し(基質の終濃度は9重量%)、45℃にて反応を行ったところ、反応液中に6-ヘプテニルグリシンが析出した。24時間攪拌後、反応液中の基質及び生成物を高速液体クロマトグラフィーにて分析することにより、変換率(mol%)を求めた結果、変換率は99.6mol%であった。更に生成物を二炭酸ジtert-ブチルでN-tert-ブトキシカルボニル6-ヘプテニルグリシンへと誘導化し高速液体クロマトグラフィーにて光学純度(%e.e.)分析を行ったところ、100%e.e.であった。変換率より算出されるL-6-ヘプテニルグリシンの蓄積濃度は5.7重量%であった。また、L-6-ヘプテニルグリシンの溶解濃度を高速液体クロマトグラフィーにて定量分析測定したところ、0.5重量%以下であった。 Example 7 Production of L-6-heptenylglycine using a transformant transformed with a vector containing L-succinylase and N-acylamino acid racemase gene N-succinyl-DL in the same manner as in Example 5. A substrate solution (pH 8) of -6-heptenylglycine was prepared, and an aqueous cobalt chloride solution was added to a final concentration of 1 mM, followed by culturing in the same manner as in Example 6 . When a culture solution of E. coli HB101 (pNIGHK) was mixed (final substrate concentration was 9% by weight) and reacted at 45 ° C., 6-heptenylglycine was precipitated in the reaction solution. After stirring for 24 hours, the conversion rate (mol%) was determined by analyzing the substrate and product in the reaction solution by high performance liquid chromatography. As a result, the conversion rate was 99.6 mol%. Further, the product was derivatized with di-tert-butyl dicarbonate to N-tert-butoxycarbonyl 6-heptenylglycine, and optical purity (% ee) analysis was performed by high performance liquid chromatography. . e. Met. The accumulated concentration of L-6-heptenylglycine calculated from the conversion rate was 5.7% by weight. Further, when the dissolved concentration of L-6-heptenylglycine was quantitatively analyzed and measured by high performance liquid chromatography, it was 0.5% by weight or less.
[変換率の分析]
カラム:YMC-A303(4.6mmφ×250mm、YMC社製)
溶離液:20mMリン酸水溶液(pH2.5)/アセトニトリル=1/1
流速:1.0ml/分
カラム温度:35℃
測定波長:210nm
[光学純度の分析]
カラム:CHIRALPAK AD-RH(4.6mmφ×150mm、ダイセル社製)
溶離液:0.02% リン酸水溶液(pH2.5)/アセトニトリル=65/35
流速:0.7ml/分
カラム温度:35℃ <High-performance liquid chromatography analysis conditions>
[Conversion rate analysis]
Column: YMC-A303 (4.6 mmφ × 250 mm, manufactured by YMC)
Eluent: 20 mM phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 1/1
Flow rate: 1.0 ml / min Column temperature: 35 ° C
Measurement wavelength: 210 nm
[Analysis of optical purity]
Column: CHIRALPAK AD-RH (4.6 mmφ × 150 mm, manufactured by Daicel)
Eluent: 0.02% phosphoric acid aqueous solution (pH 2.5) / acetonitrile = 65/35
Flow rate: 0.7 ml / min Column temperature: 35 ° C
Claims (10)
- N-サクシニルアミノ酸のエナンチオマー混合物にL-サクシニラーゼを作用させて、L-アミノ酸を製造する方法であって、N-アシルアミノ酸ラセマーゼの共存下に、生成させたL-アミノ酸を析出させつつ反応を行うことを特徴とするL-アミノ酸の製造方法。 A method for producing an L-amino acid by reacting an enantiomeric mixture of N-succinylamino acids with an L-succinylase, wherein the reaction is performed in the presence of an N-acylamino acid racemase while precipitating the produced L-amino acid. A process for producing an L-amino acid,
- 上記L-アミノ酸の溶解濃度が1重量%以下である請求項1に記載の製造方法。 The process according to claim 1, wherein the L-amino acid has a dissolution concentration of 1% by weight or less.
- 上記N-サクシニルアミノ酸が一般式(I);
- 上記式(I)及び(II)においてRが4-ブロモベンジル基、3-フルオロベンジル基、ナフチルメチル基、インダニル基、または6-ヘプテニル基である請求項3記載の製造方法。 The production method according to claim 3, wherein in the formulas (I) and (II), R is a 4-bromobenzyl group, a 3-fluorobenzyl group, a naphthylmethyl group, an indanyl group, or a 6-heptenyl group.
- N-アシルアミノ酸ラセマーゼがゲオバチルス(Geobacillus)属或いはサーマス(Thermus)属、L-サクシニラーゼがゲオバチルス(Geobacillus)属に属する微生物由来である請求項1~4のいずれか1項に記載の製造方法。 N- acylamino acid racemase Geobacillus (Geobacillus) genus or Thermus (Thermus) genus The method according to any one of claims 1 ~ 4 L-Sakushiniraze is derived from a microorganism belonging to the Geobacillus (Geobacillus) genus.
- N-アシルアミノ酸ラセマーゼがゲオバチルス・カウストフィラス(Geobacillus kaustophilus)、サーマス・サーモフィラス(Thermus thermophilus)、L-サクシニラーゼがゲオバチルス・カウストフィラス(Geobacillus kaustophilus)由来である請求項5に記載の製造方法。 6. The production method according to claim 5, wherein the N-acylamino acid racemase is derived from Geobacillus kaustophilus , Thermus thermophilus , and L-succinylase is derived from Geobacillus kaustophilus .
- N-アシルアミノ酸ラセマーゼがゲオバチルス・カウストフィラス(Geobacillus kaustophilus)NBRC102445、サーマス・サーモフィラス(Thermus thermophilus)HB8、L-サクシニラーゼがゲオバチルス・カウストフィラス(Geobacillus kaustophilus)NBRC102445由来である請求項6に記載の製造方法。 The N-acylamino acid racemase is derived from Geobacillus kaustophilus NBRC102445, Thermus thermophilus HB8, and L-succinylase is derived from Geobacillus kaustophilus NBRC102445.
- N-アシルアミノ酸ラセマーゼとL-サクシニラーゼが、N-アシルアミノ酸ラセマーゼとL-サクシニラーゼをコードするDNAを含むベクターで形質転換された形質転換体である請求項1~4のいずれか1項に記載の製造方法。 The N-acylamino acid racemase and L-succinylase are transformants transformed with a vector containing DNA encoding the N-acylamino acid racemase and L-succinylase, according to any one of claims 1 to 4. Production method.
- 一般式(III);
- 上記式(III)においてRが4-ブロモベンジル基、3-フルオロベンジル基、2-ナフチルメチル基、2-インダニル基、または6-ヘプテニル基である請求項9記載のN-サクシニルアミノ酸またはその塩。 10. The N-succinyl amino acid or a salt thereof according to claim 9, wherein in the formula (III), R is a 4-bromobenzyl group, a 3-fluorobenzyl group, a 2-naphthylmethyl group, a 2-indanyl group, or a 6-heptenyl group. .
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/126,534 US9464306B2 (en) | 2008-10-29 | 2009-10-28 | Method for producing L-amino acid |
CN200980143175.5A CN102203274B (en) | 2008-10-29 | 2009-10-28 | The manufacture method of L aminoacid |
JP2010535820A JP5744521B2 (en) | 2008-10-29 | 2009-10-28 | Method for producing L-amino acid |
EP09823626.8A EP2351848B1 (en) | 2008-10-29 | 2009-10-28 | Method for producing l-amino acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008-277674 | 2008-10-29 | ||
JP2008277674 | 2008-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010050516A1 true WO2010050516A1 (en) | 2010-05-06 |
Family
ID=42128875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/068515 WO2010050516A1 (en) | 2008-10-29 | 2009-10-28 | Method for producing l-amino acid |
Country Status (6)
Country | Link |
---|---|
US (1) | US9464306B2 (en) |
EP (1) | EP2351848B1 (en) |
JP (2) | JP5744521B2 (en) |
CN (1) | CN102203274B (en) |
SG (1) | SG10201400650QA (en) |
WO (1) | WO2010050516A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10059969B1 (en) | 2014-10-03 | 2018-08-28 | Abbvie Inc. | Process for the preparation of (S)-2-amino-non-8-enoic acid |
US10113152B1 (en) | 2014-10-03 | 2018-10-30 | Abbvie Inc. | Variant polypeptides capable of aminating aliphatic alpha keto acids |
US10689675B2 (en) | 2017-02-01 | 2020-06-23 | Abbvie Inc. | Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010050516A1 (en) | 2008-10-29 | 2010-05-06 | 株式会社カネカ | Method for producing l-amino acid |
CN107064369A (en) * | 2017-04-24 | 2017-08-18 | 精晶药业股份有限公司 | The quantitative detecting method of beta Alanine and its application |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2566410A1 (en) * | 1984-06-20 | 1985-12-27 | Delalande Sa | New diaminopimelic acid derivatives, a process for preparing them and their therapeutic application |
JP2001046088A (en) | 1999-07-27 | 2001-02-20 | Degussa Huels Ag | N-acetylamino acid racemase, its coating gene, plasmid, vector and microorganism having the same gene, primer and sonde for the same gene and use of racemase |
JP2001314191A (en) | 2000-03-01 | 2001-11-13 | Daicel Chem Ind Ltd | Method for racemizing N-acyl-amino acids and method for producing optically active amino acids |
JP2002238581A (en) | 2001-02-21 | 2002-08-27 | Daicel Chem Ind Ltd | N-acyl amino acid racemase gene and use thereof |
JP2006254789A (en) | 2005-03-17 | 2006-09-28 | Toyobo Co Ltd | Method for improving the activity of D-aminoacylase |
JP2007082534A (en) | 2005-08-22 | 2007-04-05 | Toyobo Co Ltd | Heat-resistant N-acylamino acid racemase, process for producing the same, and use thereof |
JP2008061642A (en) | 2006-08-10 | 2008-03-21 | Toyobo Co Ltd | Method for producing D-amino acid |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62288A (en) * | 1985-03-09 | 1987-01-06 | Sanraku Inc | Production of l-amino acid by fermentation method |
JPH0653065B2 (en) | 1989-09-07 | 1994-07-20 | 国税庁長官 | β-phenethyl alcohol, β-phenethyl acetate high-producing yeast strain, breeding method thereof, and liquor production method using the same |
JPH0592944A (en) | 1991-07-16 | 1993-04-16 | Ajinomoto Co Inc | Production of amino acid-nucleic acid or its derivative |
JPH0585999A (en) | 1991-09-27 | 1993-04-06 | Suntory Ltd | 2-indanylglycine and its related compound |
JP2697996B2 (en) | 1992-06-17 | 1998-01-19 | 日華化学株式会社 | Dye fixative |
JP3873512B2 (en) | 1999-03-25 | 2007-01-24 | 三菱化学株式会社 | Method for producing D-3- (2-naphthyl) alanine |
JP4427878B2 (en) | 1999-08-20 | 2010-03-10 | 味の素株式会社 | Method for producing L-glutamic acid by fermentation method with precipitation |
DE10050123A1 (en) * | 2000-10-11 | 2002-04-25 | Degussa | Process for the production of amino acids |
RU2263678C2 (en) | 2001-03-08 | 2005-11-10 | Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд | Somatostatin antagonists |
RU2335495C2 (en) * | 2005-06-15 | 2008-10-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | N-acyl derivatives of aminoacids, their pharmaceutically acceptable salts, pharmaceutical composition and application as hypolipidemic preparations |
JP2010110216A (en) | 2007-02-20 | 2010-05-20 | Ajinomoto Co Inc | Method for producing l-amino acid or nucleic acid |
JP2008307006A (en) | 2007-06-15 | 2008-12-25 | Toyobo Co Ltd | Method for producing l-amino acid |
WO2009136500A1 (en) | 2008-05-07 | 2009-11-12 | 東洋紡績株式会社 | L-succinyl aminoacylase and process for producing an l-amino acid using the same |
WO2010050516A1 (en) | 2008-10-29 | 2010-05-06 | 株式会社カネカ | Method for producing l-amino acid |
-
2009
- 2009-10-28 WO PCT/JP2009/068515 patent/WO2010050516A1/en active Application Filing
- 2009-10-28 US US13/126,534 patent/US9464306B2/en active Active
- 2009-10-28 CN CN200980143175.5A patent/CN102203274B/en active Active
- 2009-10-28 JP JP2010535820A patent/JP5744521B2/en active Active
- 2009-10-28 SG SG10201400650QA patent/SG10201400650QA/en unknown
- 2009-10-28 EP EP09823626.8A patent/EP2351848B1/en active Active
-
2015
- 2015-01-27 JP JP2015013526A patent/JP6039710B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2566410A1 (en) * | 1984-06-20 | 1985-12-27 | Delalande Sa | New diaminopimelic acid derivatives, a process for preparing them and their therapeutic application |
JP2001046088A (en) | 1999-07-27 | 2001-02-20 | Degussa Huels Ag | N-acetylamino acid racemase, its coating gene, plasmid, vector and microorganism having the same gene, primer and sonde for the same gene and use of racemase |
JP2001314191A (en) | 2000-03-01 | 2001-11-13 | Daicel Chem Ind Ltd | Method for racemizing N-acyl-amino acids and method for producing optically active amino acids |
JP2002238581A (en) | 2001-02-21 | 2002-08-27 | Daicel Chem Ind Ltd | N-acyl amino acid racemase gene and use thereof |
JP2006254789A (en) | 2005-03-17 | 2006-09-28 | Toyobo Co Ltd | Method for improving the activity of D-aminoacylase |
JP2007082534A (en) | 2005-08-22 | 2007-04-05 | Toyobo Co Ltd | Heat-resistant N-acylamino acid racemase, process for producing the same, and use thereof |
JP2008061642A (en) | 2006-08-10 | 2008-03-21 | Toyobo Co Ltd | Method for producing D-amino acid |
Non-Patent Citations (4)
Title |
---|
"Current Protocols in Molecular Biology", GREENE PUBLISHING ASSOCIATES AND WILEY-INTERSCIENCE |
"Molecular Cloning", 1989, COLD SPRING HARBOR LABORATORY PRESS |
BIOCHEMISTRY, vol. 43, 2004, pages 224 |
BIOCHEMISTRY, vol. 45, 2006, pages 4455 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10059969B1 (en) | 2014-10-03 | 2018-08-28 | Abbvie Inc. | Process for the preparation of (S)-2-amino-non-8-enoic acid |
US10113152B1 (en) | 2014-10-03 | 2018-10-30 | Abbvie Inc. | Variant polypeptides capable of aminating aliphatic alpha keto acids |
US10465216B2 (en) | 2014-10-03 | 2019-11-05 | Abbvie Inc. | Process for the preparation of (S)-2-amino-non-8-enoic acid |
US10689675B2 (en) | 2017-02-01 | 2020-06-23 | Abbvie Inc. | Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid |
Also Published As
Publication number | Publication date |
---|---|
US9464306B2 (en) | 2016-10-11 |
CN102203274B (en) | 2017-04-05 |
EP2351848A4 (en) | 2016-08-17 |
SG10201400650QA (en) | 2014-05-29 |
JP5744521B2 (en) | 2015-07-08 |
US20110229940A1 (en) | 2011-09-22 |
EP2351848A1 (en) | 2011-08-03 |
CN102203274A (en) | 2011-09-28 |
EP2351848B1 (en) | 2018-02-28 |
JP6039710B2 (en) | 2016-12-07 |
JPWO2010050516A1 (en) | 2012-03-29 |
JP2015091265A (en) | 2015-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6039710B2 (en) | Method for producing L-amino acid | |
WO2010067613A1 (en) | L-succinyl aminoacylase and process for producing l-amino acid using same | |
JP5516664B2 (en) | N-acetyl- (R, S) -β-amino acid acylase gene | |
JP7401116B2 (en) | Novel L-amino acid oxidase and method for producing D-amino acid or derivatives thereof | |
JPWO2011078172A1 (en) | Process for producing optically active 3-substituted glutaric monoamide | |
WO2012124513A1 (en) | Modified d-succinylase having improved d-form selectivity for n-succinyl-dl-amino acid | |
EP1646718A2 (en) | Methods for the stereoselective synthesis and enantiomeric enrichment of b-amino acids | |
Kamphuis et al. | New developments in the synthesis of natural and unnatural amino acids | |
US6800464B2 (en) | Arthrobacter D-carbamoylase and methods of preparing enantiomerically enriched D-amino acids | |
JP5119783B2 (en) | N-acetyl- (R, S) -β-amino acid acylase gene | |
US6812008B2 (en) | Esterase genes and uses of the same | |
EP1506294B1 (en) | Hydantoin racemase | |
WO2011118450A1 (en) | Method for manufacturing an optically active n-methyl amino acid and an optically active n-methyl amino acid amide | |
JP4650421B2 (en) | L-form amino acid amide asymmetric hydrolase and DNA encoding the same | |
JP5595400B2 (en) | Process for producing optically active 3-substituted glutaric monoamide | |
JP6088973B2 (en) | New amidase | |
WO2011001889A1 (en) | METHOD FOR RACEMIZING OPTICALLY ACTIVE α-AMINO ACIDS | |
KR20030072067A (en) | Novel thermophilic microorganism and methods for producing l-type aromatic amino acids by using the same | |
JPWO2004063385A1 (en) | Process for producing optically active α-methylcysteine derivative | |
JP2011024572A (en) | Method for producing optically active amino acid | |
JP2008193914A (en) | Methods for adding fatty acids to amino acids, peptides, and proteins | |
JP2004267059A (en) | Method for producing optically active 2-hydroxy-2-trifluoroacetic acid compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980143175.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09823626 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010535820 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1832/KOLNP/2011 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009823626 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13126534 Country of ref document: US |